The function role of GATA-3 in Th1 and Th2 differentiation

Immunologic Research

Volumn 28, Issue 1, 2003, Pages 25-37

  Zhou, Meixia ^a   Ouyang, Wenjun ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GENENTECH INC   (United States)

Author keywords

Cytokines; GATA 3; IFN ; IL 4; Th1; Th2; Transcription factors

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; PROTEIN BCL 6; STAT6 PROTEIN; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GATA 3;

CELL DIFFERENTIATION; CELL MATURATION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING; REVIEW; TH1 CELL; TH2 CELL;

ANIMALS; CELL DIFFERENTIATION; CYTOKINES; DNA-BINDING PROTEINS; GATA3 TRANSCRIPTION FACTOR; HUMANS; TH1 CELLS; TH2 CELLS; TRANS-ACTIVATORS;

EID: 0041374389     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:28:1:25     Document Type: Review

References (96)

1. Mosmann TR, Cherwinski H, Bond HW, Giedlin MA, Coffman RL: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-2357.
2. Stenger S, Thuring H, Rollinghoff M, Bogdan C: Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J Exp Med 1994; 180(3):783-793.
3. Reiner SL, Seder RA: T helper cell differentiation in immune response. Curr Opin Immunol 1995;7(3):360-366.
4. Farrar MA, Schreiber RD:The molecular cell biology of interferongamma and its receptor. Annu Rev Immunol 1993;11:571-611.
5. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, et al.: Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326(5):298-304.
6. Erb KJ, Le Gros G: The role of Th2 type CD4+ T cells and Th2 type CD8+ T cells in asthma. Immunol Cell Biol 1996;74(2):206-208.
7. Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H, Kohler G: Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993;362(6417):245-248.
8. Kuhn R, Rajewsky K, Muller W: Generation and analysis of interleukin-4 deficient mice. Science 1991;254(5032):707-710.
9. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 1996;383(6603):787-793.
10. Seder RA, Paul WE: Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol 1994;12:635-673.
11. Mosley B, Beckmann MP, March CJ, Idzerda RL, Gimpel SD, VandenBos T, et al.: The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell 1989;59(2):335-348.
12. Miyazaki T, Kawahara A, Fujii H, Nakagawa Y, Minami Y, Liu ZJ, et al.: Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 1994;266(5187):1045-1047.
13. Yin T, Tsang ML, Yang YC: JAK1 kinase forms complexes with interleukin-4 receptor and 4PS/insulin receptor substrate-1-like protein and is activated by interleukin-4 and interleukin-9 in T lymphocytes. J Biol Chem 1994;269(43):26,614-26,617.
14. Hou J, Schindler U, Henzel WJ, Ho TC, Brasseur M, McKnight SL: An interleukin-4-induced transcription factor: IL-4 Stat. Science 1994;265 (5179):1701-1706.
15. Quelle FW, Shimoda K, Thierfelder W, Fischer C, Kim A, Ruben SM, et al.: Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol Cell Biol 1995;15(6):3336-3343.
16. Shimoda K, van Deursen J, Sangster MY, Sarawar SR, Carson RT, Tripp RA, et al.: Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 1996;380(6575):630-633.
17. Takeda K, Kamanaka M, Tanaka T, Kishimoto T, Akira S: Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice. J Immunol 1996;157(8):3220-3222.
18. Orkin SH: Hematopoiesis: how does it happen? Curr Opin Cell Biol 1995;7(6):870-877.
19. Pandolfi PP, Roth ME, Karis A, Leonard MW, Dzierzak E, Grosveld FG, et al.: Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nat Genet 1995;11:40-44.
20. Ting CN, Olson MC, Barton KP, Leiden JM: Transcription factor GATA-3 is required for development of the T-cell lineage. Nature 1996;384:474-478.
21. Zheng W., Flavell RA: The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997;89:587-596.
22. Siegel MD, Zhang DH, Ray P, Ray A: Activation of the interleukin-5 promoter by cAMP in murine EL-4 cells requires the GATA-3 and CLE0 elements. J Biol Chem 1995;270(41):24,548-24,555.
23. Zhang DH, Cohn L, Ray P, Bottomly K, Ray A: Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J Biol Chem 1997;272:21,597-21,603.
24. Ouyang W., Ranganath SH, Weindel K, Bhattacharya D, Murphy TL, Sha W, et al.: Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 1998;9:745-755.
25. Ouyang W., Lohning M, Gao M, Assenmacher M, Ranganath M, Radbruch A, et al.: Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. Immunity 2000;12:27-37.
26. Li-Weber M., Davydov IV, Krafft H, Krammer PH: The role of NF-Y and IRF-2 in the regulation of human IL-4 gene expression. J Immunol 1994;153:4122-4133.
27. Szabo SJ, Gold JS, Murphy TL, Murphy KM: Identification of cis-acting regulatory elements controlling interleukin-4 gene expression in T cells: roles for NF-Y and NF-ATc [published erratum appears in Mol Cell Biol 1993;13(9):5928]. Mol Cell Biol 1993;13:4793-4805.
28. Rooney JW, Hoey T, Glimcher LH: Coordinate and cooperative roles for NF-AT and AP-1 in the regulation of the murine IL-4 gene. Immunity 1995;2:473-483.
29. Murphy KM, Ouyang W, Farrar JD, Yang J, Ranganath S, Asnagli H, et al.: Signaling and transcription in T helper development. Annu Rev Immunol 2000;18:451-494.
30. Wenner CA, Szabo SJ, Murphy KM: Identification of IL-4 promoter elements conferring Th2-restricted expression during T helper cell subset development. J Immunol 1997;158:765-773.
31. Ranganath S, Ouyang W, Bhattarcharya D, Sha WC, Grupe A, Peltz G, et al.: GATA-3-dependent enhancer activity in IL-4 gene regulation. J Immunol 1998;161:3822-3826.
32. Zhang DH, Yang L, Ray A: Differential responsiveness of the IL-5 and IL-4 genes to transcription factor GATA-3. J Immunol 1998;161:3817-3821.
33. Agarwal S, Rao A: Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 1998;9:765-775.
34. Lee HU, Takemoto N, Kurata H, Kamogawa Y, Miyatake S, O'Garra A, et al.: GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Thl cells. J Exp Med 2000;192(1):105-115.
35. Takemoto N, Kamogawa Y, Jun Lee H, Kurata H, Arai KI, O'Garra A, et al.: Chromatin remodeling at the IL-4/IL-13 intergenic regulatory region for Th2-specific cytokine gene cluster. J Immunol 2000;165:6687-6691.
36. Loots GG, Locksley RM, Blankespoor CM, Wang ZE, Miller W, Rubin EM, et al.: Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons. Science 2000;288(5463):136-140.
37. Lee GR, Fields PE, Flavell RA: Regulation of IL-4 gene expression by distal regulatory elements and GATA-3 at the chromatin level. Immunity 2001;14(4):447-459.
38. Schwenger GT, Fournier R, Kok CC, Mordvinov VA, Yeoman D, Sanderson CJ: GATA-3 has dual regulatory functions in human interleukin-5 transcription. J Biol Chem 2001;276(51):48,502-48,509.
39. Defrance T, Carayon P, Billian G, Guillemot JC, Minty A, Caput D, et al.: Interleukin 13 is a B cell stimulating factor. J Exp Med 1994;179(1):135-143.
40. Emson CL, Bell SE, Jones A, Wisden W, McKenzie AN: Interleukin (IL)-4-independent induction of immunoglobulin (Ig)E, and perturbation of T cell development in transgenic mice expressing IL-13. J Exp Med 1998;188(2):399-404.
41. Kishikawa H, Sun J, Choi A, Miaw SC, Ho IC: The cell type-specific expression of the murine IL-13 gene is regulated by GATA-3. J Immunol 2001;167(8):4414-4420.
42. Rao A., Luo C, Hogan PG: Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 1997;15:707-747.
43. Agarwal S, Avni O, Rao A: Cell-type-restricted binding of the transcription factor NFAT to a distal IL-4 enhancer in vivo. Immunity 2000;12(6):643-652.
44. Glimcher LH, Singh H: Transcription factors in lymphocyte development - T and B cells get together. Cell 1999;96:13-23.
45. Ranger AM, Hodge MR, Gravallese EM, Oukka M, Davidson L, Alt FW, et al.: Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc. Immunity 1998;8:125-134.
46. Yoshida H, Nishina H, Takimoto H, Marengere LE, Wakeham AC, Bouchard D, et al.: The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production. Immunity 1998;8:115-124.
47. Hodge MR, Ranger AM, Charles de la Brousse F, Hoey T, Grusby MJ, Glimcher LH: Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity 1996;4:397-405.
48. Xanthoudakis S., Viola JP, Shaw KT, Luo C, Wallace JD, Bozza PT, et al.: An enhanced immune response in mice lacking the transcription factor NFAT1 [published erratum appears in Science 1996;273(5280):1325]. Science 1996;272:892-895.
49. Hodge MR, Chun HJ, Rengarajan J, Alt A, Lieberson R, Glimcher LH. NF-AT-driven interleukin-4 transcription potentiated by NIP45. Science 1996;274:1903-1905.
50. Dong C, Yang DD, Wysk M, Whitmarsh AJ, Davis RJ, Flavell RA: Defective T cell differentiation in the absence of Jnk1. Science 1998;282:2092-2095.
51. Chow CW, Rincon M, Cavanagh J, Dickens M, Davis RJ: Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway. Science 1997;278:1638-1641.
52. Li B, Tournier C, Davis RJ, Flavell RA: Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation. EMBO J 1999;18:420-432.
53. Rincon M, Derijard B, Chow CW, Davis RJ, Flavell RA: Reprogramming the signalling requirement for AP-1 (activator protein-1) activation during differentiation of precursor CD4+ T-cells into effector Th1 and Th2 cells. Genes Function 1997;1:51-68.
54. Ho IC, Hodge MR, Rooney JW, Glimcher LH: Theproto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 1996;85(7):973-983.
55. Ho IC, Lo D, Glimcher LH: c-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin 4-dependent and -independent mechanisms. J Exp Med 1998;188(10):1859-1866.
56. Kim JI, Ho IC, Grusby MJ, Glimcher LH: The transcription factor c-Mar controls the production of interleukin-4 but not other Th2 cytokines. Immunity 1999;10(6):745-751.
57. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM: Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993;260(5107):547-549.
58. Magram J, Connaughton SE, Warrier RR, Carvajal DM, Wu CY, Ferrante J, et al.: IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 1996;4(5):471-481.
59. Piccotti JR, Li K, Chan SY, Ferrante J, Magram J, Eichwald EJ, et al.: Alloantigen-reactive Th1 development in IL-12-deficient mice. J Immunol 1998;160:1132-1138.
60. de Jong R, Altare F, Haagen IA, Elferink DG, van Boer T, Vriesman PJ, et al.: Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 1998;280:1435-1438.
61. Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le Deist F, et al.: Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998;280:1432-1435.
62. Trinchieri G, Scott P: Interleukin-12: a proinflammatory cytokine with immunoregulatory functions. Res Immunol 1995;146(7-8):423-431.
63. Chua AO, Chizzonite R, Desai BB, Truitt TP, Nunes P, Minetti LJ, et al: Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130. J Immunol 1994;153(1):128-136.
64. Presky DH, Yang H, Minetti LJ, Chua AO, Nabavi N, Wu CY, et al.: A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci USA 1996;93(24):14,002-14,007.
65. Szabo SJ, Dighe AS, Gubler U, Murphy KM: Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper1 (Th1) and Th2 cells. J Exp Med 1997;185(5):817-824.
66. Naeger LK, McKinney J, Salvekar A, Hoey T: Identification of a STAT4 binding site in the interleukin-12 receptor required for signaling. J Biol Chem 1999;274(4):1875-1878.
67. Jacobson NG, Szabo SJ, Weber-Nordt RM, Zhong Z, Schreiber RD, Darnell JE Jr, et al.: Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Star)3 and Stat4 J Exp Med 1996;181(5):1755-1762.
68. Kaplan MH, Sun YL, Hoey T, Grusby MJ: Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 1999;382(6587):174-177.
69. Ouyang W, Jacobson NG, Bhattacharya D, Gorham JD, Fenoglio D, Sha WC, et al.: The Ets transcription factor ERM is Th1-specific and induced by IL-12 through a Stat4-dependent pathway. Proc Natl Acad Sci USA 1999;96(7):3888-3893.
70. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH: A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000;100(6):655-669.
71. Szabo SJ, Sullivan BM, Stemmann C, Satoskar AR, Sleckman BP, Glimcher LH: Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 2002;295(5553):338-342.
72. Mullen AC, High FA, Hutchins AS, Lee HW, Villarino AV, Livingston DM, et al.: Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 2001;292(5523):1907-1910.
73. Rodriguez-Palmero M, Hara T, Thumbs A, Hunig T: Triggering of T cell proliferation through CD28 induces GATA-3 and promotes T helper type 2 differentiation in vitro and in vivo. Eur J Immunol 1999;29(12):3914-3924.
74. Chen CH, Zhang DH, LaPorte JM, Ray A: Cyclic AMP activates p38 mitogen-activated protein kinase in Th2 cells: phosphorylation of GATA-3 and stimulation of Th2 cytokine gene expression. J Immunol 2000;165(10):5597-5605.
75. Gorelik L, Fields PE, Flavell RA: Cutting edge: TGF-beta inhibits Th type 2 development through inhibition of GATA-3 expression J Immunol 2000;165(9):4773-4777.
76. Heath VL, Murphy EE, Crain C, Tomlinson MG, O'Garra A: TGF-beta1 down-regulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression. Eur J Immunol 2000;30(9):2639-2649.
77. Blokzijl A, ten Dijke P, Ibanez CF: Physical and functional interaction between GATA-3 and Smad3 allows TGF-beta regulation of GATA target genes. Curr Biol 2002;12(1):35-45.
78. Lee HJ, Takemoto N, Kurata H, Kamogawa Y, Miyatake S, O'Garra A, et al.: GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells. J Exp Med 2000;192(1):105-115.
79. Zhou M, Ouyang W, Gong Q, Katz SG, White JM, Orkin SH, et al.: Friend of GATA-1 represses GATA-3-dependent activity in CD4+ T cells. J Exp Med 2001;194(10):1461-1471.
80. Ranganath S, Murphy KM: Structure and specificity of GATA proteins in Th2 development. Mol Cell Biol 2001;21(8):2716-2725.
81. Dasen JS, O'Connell SM, Flynn SE, Treier M, Gleiberman AS, Szeto DP, et al.: Reciprocal interactions of Pit1 and GATA2 mediate signaling gradient-induced determination of pituitary cell types. Cell 1999;97:587-598.
82. Tsai SF, Strauss E, Orkin SH: Functional analysis and in vivo footprinting implicate the erythroid transcription factor GATA-1 as a positive regulator of its own promoter Genes Dev 1991;5(6):919-931.
83. Das J, Chen CH, Yang L, Cohn L, Ray P, Ray A: A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat Immunol 2001;2(1):45-50.
84. Tsang AP, Visvader JE,Turner CA, Fujiwara Y, Yu C, Weiss MJ, et al.: FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation Cell 1997;90(1):109-119.
85. Tsang AP, Fujiwara Y, Hom DB, Orkin SH: Failure of megakaryopoiesis and arrested erythropoiesis in mice lacking the GATA-1 transcriptional cofactor FOG. Genes Dev 1998;12(8):1176-1188.
86. Cubadda Y, Heitzler P, Ray RP, Bourouis M, Ramain P, Gelbart W, et al.: U-Shaped encodes a zinc finger protein that regulates the proneural genes achaete and scute during the formation of bristles in Drosophila. Genes Dev 1997;11(22):3083-3095.
87. Tevosian SG, Deconinck AE, Cantor AB, Rieff HI, Fujiwara Y, Corfas G, et al.: FOG-2: a novel GATA-family cofactor related to multitype zinc-finger proteins friend of GATA-1 and U-shaped. Proc Natl Acad Sci USA 1999;96(3):950-955.
88. Svensson EC, Tufts RL, Polk CE, Leiden JM: Molecular cloning of FOG-2: a modulator of transcription factor GATA-4 in cardiomyocytes. Proc Natl Acad Sci USA 1999;96(3):956-961.
89. Miaw SC, Choi A, Yu E, Kishikawa H, Ho IC: ROG, repressor of GATA, regulates the expression of cytokine genes. Immunity 2000;12(3):323-333.
90. Dent AL, Shaffer AL, Yu X, Allman D, Staudt LM: Control of inflammation, cytokine expression, and germinal center formation by BCL. Science 1997;276(5312):589-592.
91. Dent AL, Hu-Li J, Paul WE, Staudt LM: T helper type 2 inflammatory disease in the absence of interleukin 4 and transcription factor STAT6. Proc Natl Acad Sci USA 1998;95(23):13,823-13,828.
92. Toney LM, Cattoretti G, Graf JA, Merghouh T, Pandolfi PP, Dalla-Favera R, et al.: BCL-6 regulates chemokine gene transcription in macrophages. Nat Immunol 2000;1(3):214-220.
93. Gourley T, Roys S, Lukacs NW, Kunkel SL, Flavell RA, Chang CH: A novel role for the major histocompatibility complex class II transactivator CIITA in the repression of IL-4 production. Immunity 1999;10(3):377-386.
94. Nakamura Y, Ghaffar O, Olivenstein R, Taha RA, Soussi-Gounni A, Zhang DH, et al.: Gene expression of the GATA-3 transcription factor is increased in atopic asthma. J Allergy Clin Immunol 1999;103(2):215-222.
95. Finotto S, De Sanctis GT, Lehr HA, Herz U, Buerke M, Schipp M, et al.: Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression. J Exp Med 2001;193(11):1247-1260.
96. Zhang DH, Yang L, Cohn L, Parkyn L, Homer R, Ray P, et al.: Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3. Immunity 1999;11(4):473-482.